Advances on supramolecular assembly of cyclometalated platinum(Ⅱ) complexes

Organoplatinum(Ⅱ) compounds have received enormous attention over the past decades due to their square-planar geometry as well as intriguing photo-physical properties.Self-assembly has emerged as an excellent approach to create well-ordered supramolecular architectures with tunable properties,which underpin the role of solvent-directed approach for the design of functional materials.In this minireview,the recent advances on supramolecular self-assembly of cyclometalated platinum(Ⅱ) complexes have been discussed.During the self-assembly process,non-covalent Pt-Pt and π-π interactions play crucial roles in controlling the structures and functions of the resulting assemblies.     

Rhodium(III), palladium(II) and platinum(II) complexes of Bis(o-aminobenzenesulfonyl)ethylenediamine

New complexes of the formulae K₃[RhL ₃]·2 H₂O, [PdL]·H₂O and [M(LH₂)Cl₂] [whereM = Pd, Pt andLH₂ = bis(o-aminobenzenesulfonyl)ethylenediamine] have been prepared and characterized by conductivity measurements, thermogravimetric analysis, X-ray powder patterns and IR, Ligand Field and¹H-NMR spectroscopy.

---

Rhodium(III), Palladium(II)- und Platin(II)-Komplexe mit Bis(o-aminobenzolosulfonyl)ethylendiamin (Kurze Mitteilung)

Zusammenfassung Neue Komplexe der allgemeinen Formeln K₃[RhL ₃]·2H₂O, [PdL]·H₂O und [M(LH₂)Cl₂] mitM = Pd, Pt undLH₂ = Bis(o-aminobenzolosulfonyl)ethylendiamin wurden dargestellt und mit Konduktionsmessungen, thermogravimetrischen Analysen, Röntgenstrukturanalysen, IR, Ligandfeld- und¹H-NMR-Spektroskopie charakterisiert.

     

1-Methyl-4-ferrocenylmethyl-3,5-diphenylpyrazole: A versatile ligand for palladium(II) and platinum(II)

The syntheses and characterization of two novel ferrocene derivatives containing 3,5-diphenylpyrazole units of general formula [1-R-3,5-Ph₂-(C₃N₂)-CH₂-Fc] {Fc = (η⁵-C₅H₅)Fe(η⁵-C₅H₄) and R = H (2) or Me (3)} together with a study of their reactivity with palladium(II) and platinum(II) salts or complexes under different experimental conditions is described. These studies have allowed us to isolate and characterize trans-[Pd{1-Me-3,5-Ph₂-(C₃N₂)-CH₂-Fc]}₂Cl₂] (4a) and three different types of heterodimetallic complexes: cis-[M{1-Me-3,5-Ph₂-(C₃N₂)-CH₂-Fc]}Cl₂(dmso)] {M = Pd (5a) or Pt (5b)}, the cyclometallated products [M{κ²-C,N-[3-(C₆H₄)-1-Me-5-Ph-(C₃N₂)]-CH₂-Fc}Cl(L)] with L = PPh₃ and M = Pd (6a) or Pt (6b) or L = dmso and M = Pt (8b) and the trans-isomer of [Pt{1-Me-3,5-Ph₂-(C₃N₂)-CH₂-Fc]}Cl₂(dmso)] (7b). In compounds 4a, 5a, 5b and 7b, the ligand behaves as a neutral N-donor group; while in 6a, 6b and 8b it acts as a bidentate [C(sp²,phenyl),N(pyrazole)]⁻ group. A comparative study of the spectroscopic properties of the compounds, based on NMR, IR and UV-Visible experiments, is also reported.     

Traceable platinum(II) complexes with alkylene diamine-derived ligands: synthesis,characterization and in vitro studies

Diiodido- (6a/6b) and dichloridoplatinum(II) complexes (7a/7b) with fluorescent ligands 2-[(2-aminoethyl)amino]ethyl-2-(methylamino)benzoate (5a) and 2-amino-1-(aminoethyl)ethyl-2-(methylamino)benzoate (5b) were prepared and characterized by elemental analysis, ESI-MS analysis, fluorescence spectrometry, as well as ¹H, ¹³C, and ¹⁹⁵Pt NMR spectroscopy. All compounds have been tested against A2780 ovarian cancer, A549 lung carcinoma, and HT-29 colon cancer cell lines using sulforhodamine-B assay. The activity increased from ligand precursors, diiodido- to dichloridoplatinum(II) complexes, except against HT-29 cell line where diiodido and dichlorido expressed similar activity. These compounds enter the tumor cells and emit a bright fluorescence at ca. 470 nm, mainly targeting nuclei.     

DFT and TDDFT investigations on the ground and excited states for polynuclear platinum(II) complexes containing the rigid phenylacetylide ligand

We have studied the ground and excited states of the three dendritic polynuclear Pt(II) complexes 1-[Cl(PH3)2PtC≡≡ C]-3,5-[HC≡≡ C]C6H3 (1), 1,3-[Cl(PH3)2PtC≡≡ C]2-5-[HC≡≡ C]C6H3 (2), and 1,3,5-[Cl(PH3)2- PtC≡≡ C]3C6H3 (3), by using the B3LYP and UB3LYP methods, respectively. TDDFT approach with the PCM model was performed to predict the emission spectra properties of 1―3 in CH2Cl2 solution. We first predicted the excited-state geometries for the three complexes. With the change of the number of Pt(II) atom, 1―3 show the different geometry structures in both the ground and excited states; fur- thermore, the increase of the metal density from 1 to 3 results in the red shift of the lowest-energy emissions along the series. The luminescent properties of 1 are somewhat different from those of 2 and 3. The emission properties of 2 and 3 are richer than 1. Our conclusion can give a good support for designing the high efficient luminescent materials.     

Synthesis and in vitro cytotoxicity of novel dinuclear platinum(II) complexes containing a chiral tetradentate ligand

A series of novel dinuclear platinum(II) complexes with a chiral tetradentate ligand, (1R,1′R,2R,2′R)-N¹,N¹′-(1,2-phenylenebis(methylene))dicyclohexane-1,2-diamine (HL), and mono-carboxylic acid derivatives as ligands have been designed, synthesized, and characterized. In vitro cytotoxicity evaluation of synthesized complexes against human HepG-2, A549, HCT-116, and MCF-7 cancer cell lines has been conducted by MTT assays. All compounds showed antitumor activity to HepG-2 and HCT-116 cell lines. Compound L2 exhibited better cytotoxicity than that of carboplatin against HepG-2 and A549 cell lines and also showed comparable activity against HCT-116 cell line.     

Perturbation of the NH2 pKa value of adenine in platinum(II) complexes: distinct stereochemical internucleobase effects

The degree of acidification of the exocyclic N6 amino group of the model nucleobase 9-methyladenine (9MeA) in relation to the number and site(s) of Pt(II) binding has been studied in detail. It is found that twofold Pt(II) binding to N1 and N7 lowers the pK(a) value from 16.7 in the free base to 12-8. The lowest pK(a) values are observed when the resulting N6H(-) amide group is intramolecularly stabilized by an H-bond donor such as the N6H(2) group of a suitably positioned second 9MeA ligand. Deprotonation of the N6 amino group facilitates Pt migration from N1 to N6, and subsequent reprotonation of the N1 position yields a twofold N7,N6-metalated form of the rare imino tautomer of 9MeA, which has a pK(a) value of 5.03. These findings demonstrate a principle that is of potential relevance to the topic of "shifted pK(a)" values of adenine nucleobases, which is believed to be important with regard to acid-base catalysis of RNAs at physiological pH values. The principle states that a nucleobase pK(a) value can be sufficiently lowered to reach near-neutral values and that the pK(a) value of the protonated base does not necessarily have to be increased to accomplish this effect.     

Heterocyclic substituted thiosemicarbazones and their Cu(II) complexes: Synthesis,characterization and studies of substituent effects on coordination and DNA binding

By reacting thiosemicarbazides substituted on the aminic nitrogen with 5-formyluracil, several new 5-formyluracil thiosemicarbazones (H₃ut) derivatives were synthesised and characterized. These ligands, treated with copper chloride and nitrate, afforded two different kinds of compounds. In the complexes derived from copper chloride the metal atom is pentacoordinated, being surrounded by the neutral ligand binding through SNO donor atoms and by two chlorines, while the nitrate derivatives consist of monocations and nitrate anions. The copper coordination (4 + 2) involves the SNO ligand atoms, two water oxygens and an oxygen atom of a monodentate nitrate group. On varying the substituents on the thiosemicarbazidic moiety, remarkable modifications of the coordination geometry are not observed for the complexes with the same counterion. For all the compounds, interactions with DNA (calf thymus) were studied using UV–Vis spectroscopy; the nuclease activity was verified on plasmid DNA pBR 322 by electrophoresis.     

Binuclear paddle-wheel platinum(II) and platinum(III) complexes containing 4-methyl-4H-1,2,4-triazole-3-thiol ligand: Synthesis,X-ray studies,and spectroscopic characterization

The complex [Pt₂(μ-mtrzt)₄(mtrzt)₂] (1) was synthesized from the reaction of a mixture of 4-methyl-4H-1,2,4-triazole-3-thiol (Hmtrzt) and ethylenediamine (en) with K₂PtCl₄ in CH₃OH/H₂O (2:1) as solvent. The complex [Pt₂(μ-mtrzt)₄] (2) was synthesized by the same procedure as described for preparation of complex 1 but in the absence of ethylenediamine. Both complexes were characterized by elemental analysis, IR,¹H NMR,¹³C{¹H}NMR, UV-Vis, as well as luminescence spectroscopy and their structures were analyzed by single-crystal X-ray diffraction method. The X-ray structure determinations show that complexes of 1 and 2 have binuclear structures in a paddle-wheel fashion with Pt-Pt distances of 2.6628(7) and 2.7977(16)Å, respectively. In complex 1, each platinum(III) atom has a distorted octahedral coordination geometry with the sulfur atom and the second platinum subunit in axial positions and two nitrogen and two sulfur atoms in equatorial positions. Also, in complex 2, each platinum(II) atom has a distorted square-pyramidal coordination geometry with the second platinum subunit in axial position and two nitrogen and two sulfur atoms in equatorial positions. In addition, intermolecular C?H···N and C?H···S hydrogen bonds in 1 and 2 as well as intermolecular anagostic C?H···Pt and C?H···π interactions in 2 are effective in the stabilization of the crystal packing of these complexes.     

X-ray crystal structures of novel platinum(II) and palladium(II) complexes of dialkyl phosphonated phosphines

Two diethyl phosphonated phosphine ligands of formula Ph₂P(CH₂)₃PO₃Et₂ (ligand L) and Ph₂P(4-C₆H₄PO₃Et₂) (ligand L′) were used to prepare different complexes of platinum(II) (1, cis-PtCl₂L₂; 2, trans-PtCl₂L₂·H₂O; 3A and 3B, cis- and trans-PtCl₂L′₂) and palladium(II) (4, [PdCl₂L]₂; 5, trans-PdCl₂L₂·H₂O; 6, trans-PdCl₂L′₂·CH₂Cl₂). The single-crystal X-ray structure analyses of complexes 1, 2, 4-6 indicate that complexation involved only the phosphine end, whereas the strong polarization of the PO bond was highlighted by the formation of hydrogen bonds with a water molecule in 2 and 5, and with a dichloromethane molecule in 6, with an exceptionally short CH?O hydrogen bond length (C?O separation 3.094(3) Å).     

Synthesis and crystal structures of two lead(II) complexes of 4,4,4-trifluoro-1-naphthyl-1,3-butanedione ligand,subtle interplay of weak intermolecular interactions

[Pb₂(tfnb)₄ (µ-CH₃OH)] _n (1) and [Pb₂(dmp)₂(tfnb)₄] (2) (tfnb and dmp are the abbreviations for 4,4,4-trifluoro-1-naphthyl-1,3-butanedionate and 2,9-dimethyl-1,10-phenanthroline) have been synthesized and characterized by elemental analysis, IR, ¹H NMR spectroscopy, and thermal analysis. The single-crystal structure of 1 shows that the complex forms two 1-D polymeric networks containing four types of Pb²⁺ with coordination numbers seven for Pb(1) and Pb(3), five for Pb(2), and six for Pb(4). The single-crystal structure of 2 shows that the complex forms a dinuclear complex with eight-coordinate Pb(II). The supramolecular features in this complex are guided by lone-pair activity and the control of weak directional intermolecular interactions and aromatic π–π stacking interactions.     

Novel antitumor dinuclear platinum (II) complexes with a new chiral tetradentate ligand as the carrier group

Seven dinuclear platinum(II) complexes with a novel chiral tetradentate ligand, (1R,1′R,2R,2′R)‐N¹,N^1′‐(1,4‐phenylenebis(methylene))dicyclohexane‐1,2‐diamine, were designed, synthesized and spectrally characterized. All the complexes were evaluated for their in vitro cytotoxicity against human HepG‐2, A549, HCT‐116 and MCF‐7 cancer cell lines. The results indicated that all compounds showed positive biological activity against HepG‐2, A549 and HCT‐116 cancer cell lines. In particular, compounds D7 and D2 showed better activity than carboplatin against HepG‐2 and A549 and compound D7 also showed an activity close to that of oxaliplatin. Copyright © 2015 John Wiley & Sons, Ltd.     

Ruthenium(II) complexes of aroylhydrazones: structural,electrochemical and electrostatic interactions with DNA

Four Ru(II) complexes with tridentate ligands viz. (4-hydroxy-N′-(pyridin-2-yl-ethylene) benzohydrazide [Ru(L¹)(PPh₃)₂(Cl)] (1), N′-(pyridin-2-yl-methylene) nicotinohydrazide [Ru(L²)(PPh₃)₂(Cl)] (2), N′-(1H-imidazol-2-yl-methylene)-4-hydroxybenzohydrazide [Ru(L³)(PPh₃)₂(Cl)] (3), and N′-(1H-imidazol-2-yl-methylene) nicotinohydrazide [Ru(L⁴)(PPh₃)₂(Cl)] (4) have been synthesized and characterized. The methoxy-derivative of L³H (abbreviated as L³H*) exists in E configuration with torsional angle of 179.4° around C₇-N₈-N₉-C₁₀ linkage. Single crystal structures of acetonitrile coordinated ruthenium complexes of 1 and 3 having compositins as [Ru(L¹)(PPh₃)₂(CH₃CN)]Cl (1a) and [Ru(L³)(PPh₃)₂(CH₃CN)]Cl (3a) revealed coordination of tridentate ligands with significantly distorted octahedral geometry constructed by imine nitrogen, heterocyclic nitrogen, and enolate amide oxygen, forming a cis-planar ring with trans-placement of two PPh₃ groups and a coordinated acetonitrile. Ligands (L¹H-L⁴H) and their ruthenium complexes (1–4) are characterized by ¹H, ¹³C, ³¹P NMR, and IR spectral analysis. Ru(II) complexes have reversible to quasi-reversible redox behavior having Ru(II)/Ru(III) oxidation potentials in the range of 0.40–0.71 V. The DNA binding constants determined by absorption spectral titrations with Herring Sperm DNA (HS-DNA) reveal that L⁴H and 1 interact more strongly than other ligands and Ru(II) complexes. Complexes 1–3 exhibit DNA cleaving activity possibly due to strong electrostatic interactions while 4 displays intercalation.     

Preparation of Palladium(II) and Platinum(II) Phosphine Complexes Promoted by Phase-Transfer Catalysts

The synthesis of M(PR₃)₂Cl₂ (M = Pd and Pt, R = alkyl or aryl) front K₂MCl₄ (in H₂O) and PR₃ (in CH₂Cl₂) was promoted by the addition of phase-transfer catalysts (PTC). The greater the amount of PTC used, the more quickly the reaction completed. ³¹P NMR spectra of some M(PR₃)₂Cl₂ in the presence of free PR₃ were measured; these NMR resulls were used to explain problems encountered during the preparations.     

Synthesis, structure, and biological activity of mixed-ligand platinum(II) complexes with aminonitroxides

Mixed-ligand platinum complexescis-Pt^II(R⁶NH₂)(NH₃)X₂ andcis-Pt^II(R⁵NH₂)(NH₃)X₂ (R⁶ is 2,2,6,6-tetramethyl-4-piperidyl-1-oxyl and R⁵ is 2,2,5,5-tetramethyl-3-pyrrolidinyl-1-oxyl) were synthesized by either the reaction of aminonitroxides RNH₂ with Na[Pt^II(NH₃)Cl₂I] generatedin situ (for X₂=ClI) or by replacement of the iodo-chloro ligands incis-Pt¹¹(RNH₂)(NH₃)ClI by dichloro and oxalato ligands. The complexes obtained were characterized by elemental analysis and by IR, UV, and ESR spectra. Forcis-Pt¹¹(R⁵NH₂)(NH₃)Cl₂, crystal and molecular structures were determined by X-ray diffraction analysis. Cisplatin accelerates autooxidation of methyl linoleate and the platinum nitroxide complexes synthesized exhibit antioxidant properties. The rate of isolated DNA binding with the new complexes is almost as high as that for cisplatin.cis-Pt¹¹(R⁶NH₂)(NH₃)Cl₂ exhibits the highest antitumor activity. The high antitumor activity of platinum nitroxide complexes shows that the possible “radical component” is not a crucial factor in the cytotoxic action of cisplatin. Published inIzvestiya Akademii Nauk. Seriya Khimicheskaya, No. 9, pp. 1624–1630, September, 2000.     

Heterobimetallic complexes of platinum(II) with diferrocenylphenylphosphine and their in vitro activity against P388 leukaemia

Four platinum(II) complexes of the general formula cis‐[Pt{(Ferr)₂PhP}(DMSO)X₂], where X₂ = Cl₂, C₂O₄, O₂(CO)₂(C₆H₁₁)₂ and O₂(CO)₂CCH₂CH₂CH₂, have been synthesized and­characterized physicochemically and spec‐­troscopically as the first heterobimetallic platinum(II) complexes with the ligand diferrocenylphenylphosphine (Ferr = ferrocenyl). These complexes were tested in vitro against leukaemia cell line P388 using the MTT assay. The results obtained were compared with those of cisplatin, carboplatin, oxaliplatin and 5‐fluorouracil. Copyright © 1999 John Wiley & Sons, Ltd.     

Potentiometric studies of binary and ternary complexes of Zn(II) with triethylenetetramine as primary ligand and selected amino acids and DNA units as secondary ligands

The acid-base equilibria of triethylenetetramine. (Trien) and the formation equilibria of binary and ternary complexes of Zn(II) with Trien as primary ligand and some selected arnino acids and DNA units as secondary ligands have been investigated. The results showed the formation of a 11 Zn (Trien)²⁺ complex. At higher pH, the Zn (Trien)²⁺ complex is hydrolysed to give Zn (Trien) (OH)⁺ and Zn(Trien)(OH)₂ complexes. The fraction of the monohydroxo species attains a maximum of 81.3% at pH 10. The stability constantsK _Zn(Trien)A ^Zn(Trien) for the ternary complexes were determined. Histidine coordinates in a histamine-like way. Lysine and ornithine ligate by the two amino groups. Serine and methionine are bound in a glycine-like mode. However, penicillamine, cysteine and glutathione ligate partly like mercaptoethylamine and partly like mercaptopropionic acid. In the case of DNA complexes, inosine is bound through the n₁ atom. However, uracil, undine, thymine and thymidine ligate through the N₃ atom. The relative stabilities of ternary complexes are compared with those of the corresponding binary complexes in terms of logK values. The concentration distribution diagrams of the complexes are evaluated.     

Asymmetric transfer hydrogenation of ketones catalyzed by ruthenium(II) complexes bearing a chiral phosphinoferrocenyloxazoline ligand

The catalytic activity in asymmetric transfer hydrogenation of ketones using octahedral and half-sandwich (η⁵-indenyl and η⁶-arene) ruthenium(II) complexes containing the chiral ligand (4S)-2-[(S_p)-2-(diphenylphosphino)ferrocenyl]-4-(isopropyl)oxazoline (FcPN) has been explored. Catalytic studies with complex fac-[RuCl₂{η²(P,N)-FcPN}(PMe₃)₂] (1) show excellent TOF values (9600 h⁻¹). Experiments in the presence of free FcPN, which lead to an increase in conversion rates and ee values when the catalyst is complex [Ru(η⁵-C₉H₇){κ²(P,N)-FcPN}(PPh₃)][PF₆] (4) have been carried out. The characterization of the new complexes mer-trans-[RuCl₂{P(OMe)₃}₂{κ²(P,N)-FcPN}] and of the water-soluble complexes fac- and mer-trans-[RuCl₂(PTA)₂{κ²(P,N)-FcPN}] is also reported.     

Synthesis,characterization and cytotoxicity of platinum(II) complexes containing reduced amino acid ester Schiff bases

Nine platinum(II) complexes containing reduced amino acid ester Schiff bases were synthesized and characterized using spectroscopy (¹H NMR, ¹³C NMR, infrared), elemental analysis and molar conductivity. The interaction of these complexes with salmon sperm DNA was investigated by means of ultraviolet and circular dichroism spectroscopies. The potential antitumor activity of all compounds was tested in vitro on HeLa and A549 tumor cell lines. Almost all the complexes exhibited better cytotoxic activity than cisplatin against these cell lines.     

Complexes of substituted dipyridylpyridazines with palladium(II) and platinum(II)

Reactions of 3,6-bis(2′-pyridyl)pyridazine derivatives (n-dppn)¶ ¶For the n-dppn ligands, n stands for the size of the cyclic aliphatic ring on positions 4 and 5 of the pyridazine ring, n?=?5, 6, 8, and 12. with MX₂(PhCN)₂ (M?=?Pd, Pt; X?=?Cl,?Br) have been investigated. The new complexes cis-[PdCl₂(n-dppn)] (n?=?5,?6,?8,?12), cis-[PtCl₂(n-dppn)]?·?H₂O (n?=?5,?6), cis-[PtCl₂(8-dppn)] and cis-[PtBr₂(5-dppn)] have been characterized by elemental analyses, conductivity measurements, infrared, electronic and ¹H-NMR spectra.